Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

(Reuters) - Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival ...

We've got fresh evidence for how weight can quickly be regained after weight-loss programs stop – but rather than looking at ...

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Supplements were also to blame when a 53-year-old woman’s left hand suddenly went numb, according to a case study in the ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

To find relief when you have a headache, consider adding these expert-recommended foods to your diet.

If you’ve spent any time in the real world lately, chances are you’ve heard of Ozempic, Wegovy, Mounjaro or semaglutide.

Ozempic and its counterparts, including Wegovy, Mounjaro and Zepbound, have surged in popularity as a means for weight loss, fueled by celebrity endorsements and slick pharmaceutical marketing.